Significant Growth in Medicare Advantage Membership
The company reported a 30% increase in Medicare Advantage membership year-over-year, which contributed to strong revenue growth.
Robust Revenue and Adjusted EBITDA Growth
Revenue grew by 33% year-over-year, and adjusted EBITDA increased by a substantial 279%, reflecting the company's operational momentum.
Clover Assistant's Positive Impact
The Clover Assistant technology has been instrumental in improving health outcomes, including earlier diagnoses of diseases like chronic kidney disease and diabetes, and reducing hospitalizations for congestive heart failure.
Improved Financial Metrics
Adjusted net income grew by 322% year-over-year, and adjusted SG&A as a percentage of total revenue decreased by 360 basis points.
Successful Stock Buyback Program
The company successfully repurchased 5 million shares, completing the remaining $80 million authorized under its buyback program.
Positive CMS Final Rate Notice for 2026
The recent CMS final rate notice is expected to add momentum, especially with the introduction of a 4 Star PPO plan.